Transcriptomics

Dataset Information

0

Microarray analysis of rat terminal end buds at neonatal diethlstilbestrol administration rats


ABSTRACT: Diethlstilbestrol (DES) is a synthetic estrogen prescribed to several millions of pregnant women worldwide. The risk for breast cancer after age 40 in women prenatally exposed to DES has been reported, however, the precise mechanism of susceptibilities to breast cancer remains to be resolved. To understand the mechanism of effect of intrauterine exposure to DES on human mammary glands at peripubertal stage, we investigated the global gene expression profile of terminal end buds (TEBs), the target of carcinogen, in rat mammary glamds at postnatal days (PND) 35 and 49, equivalent to peripubertal stage in human, exposed to low or high dose of DES at neonatal period. In all group, the number of TEBs was gradually increased and peaked at PND35 and decreased at PND49. At PND 35 and 49, low dose of DES-treated group showed highest number of TEBs. At PND35, β- and γ-casein mRNA expression inreased 8.19-fold and 26.05-fold, respectively, and the most significant network revealed by IPA analyses showed relevance of NF-κB in low dose of DES-treated group. The present findings suggested that deregulation of mammary gland differentiation and development-related genes group may contribute to the increase of number of TEBs at critical period of carcinogen susceptibilities.

ORGANISM(S): Rattus norvegicus

PROVIDER: GSE25043 | GEO | 2010/11/06

SECONDARY ACCESSION(S): PRJNA134543

REPOSITORIES: GEO

Similar Datasets

2010-11-06 | E-GEOD-25043 | biostudies-arrayexpress
2012-03-01 | GSE32432 | GEO
2012-03-01 | E-GEOD-32432 | biostudies-arrayexpress
2018-10-12 | GSE96520 | GEO
2007-06-14 | GSE5825 | GEO
2008-10-28 | E-GEOD-13356 | biostudies-arrayexpress
2016-06-03 | GSE68973 | GEO
2008-11-06 | E-GEOD-5825 | biostudies-arrayexpress
2021-05-25 | PXD025746 | Pride
2011-09-14 | E-GEOD-32125 | biostudies-arrayexpress